Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Elevance Health, Inc. (NYSE:ELV – Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,630,000 ...

Dave Breslin, formerly head of First Republic’s private-wealth unit, runs the new firm, which is being launched as GC Wealth. The company has steadily built up a base of existing high-net-worth ...

Find insight on Santander, BlackRock, PayPal and more in the latest Market Talks covering Financial Services.

Financial services firms are prime targets for cybercriminals. These businesses handle not just money but sensitive data, ...

Earnings pressure intensified for Nifty 50 in January 2025, with 72% of companies facing downward EPS revisions. The index ...

Early in my career in the financial services industry, I had a moment of clarity that shaped my purpose-driven work. As a ...

The Covid pandemic crushed immigration and demand for Nova Credit's tech. Then its founder discovered a second line of ...